MARK activation in human blood mononuclear cells in types 1 and 2 diabetes

von V. V. Pushkarov, L. K. Sokolova, O. I. Kovzun, S. A. Cherviakova, T. S. Vatseba, V. M. Pushkarov, M. D. Tronko
Veröffentlicht 2020

Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease

von M. D. Tronko, S. A. Cherviakova, V. V. Pushkarev, Y. B. Belchina, O. I. Kovzun, V. M. Pushkarev, L. K. Sokolova
Veröffentlicht 2021

Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients

von M. D. Tronko, V. V. Pushkarev, L. K. Sokolova, S. A. Cherviakova, Yu. B. Belchina, O. I. Kovzun, V. M. Pushkarev
Veröffentlicht 2021

Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease

von V. V. Pushkarov, L. K. Sokolova, S. A. Cherviakova, Yu. B. Belchyna, O. I. Kovzun, V. M. Pushkarov, M. D. Tronko
Veröffentlicht 2021

Untitled

von M. D. Tronko, S. A. Cherviakova, V. V. Pushkarev, Y. B. Belchina, O. I. Kovzun, V. M. Pushkarev, L. K. Sokolova
Veröffentlicht 2021

Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients

von M. D. Tronko, V. V. Pushkarev, L. K. Sokolova, S. A. Cherviakova, Y. B. Belchina, O. I. Kovzun, B. B. Guda, V. M. Pushkarev
Veröffentlicht 2022

NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment

von L. K. Sokolova, V. M. Pushkarev, Yu. B. Belchina, V. V. Pushkarev, O. V. Furmanova, S. A. Cherviakova, O. I. Kovzun, M. D. Tronko
Veröffentlicht 2018